Structural and functional consequences of platinum anticancer drug binding to free and nucleosomal DNA
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Chemistry, 2010. === Vita. Cataloged from PDF version of thesis. === Includes bibliographical references. === Cisplatin, carboplatin, and oxaliplatin are three FDA-approved members of the platinum anticancer drug family. These compound...
Main Author: | Todd, Ryan Christopher, 1981- |
---|---|
Other Authors: | Stephen J. Lippard. |
Format: | Others |
Language: | English |
Published: |
Massachusetts Institute of Technology
2010
|
Subjects: | |
Online Access: | http://hdl.handle.net/1721.1/57802 |
Similar Items
-
Consequences of Cisplatin Binding on Nucleosome Structure and Dynamics
by: Todd, Ryan C., et al.
Published: (2015) -
Cellular responses against DNA damaged by platinum anticancer drugs
by: Jung, Yongwon, 1977-
Published: (2006) -
Cellular responses to platinum-based anticancer drugs
by: Yarema, Kevin J. (Kevin Jon)
Published: (2006) -
Non-covalent DNA-binding ruthenium anticancer drugs
by: Leczkowska, Anna
Published: (2011) -
Synthetic strategies for the design of platinum anticancer drug candidates
by: Wilson, Justin Jeff
Published: (2013)